155 related articles for article (PubMed ID: 21691037)
1. Irbesartan prevents metabolic syndrome in rats via activation of peroxisome proliferator-activated receptor γ.
Takai S; Jin D; Miyazaki M
J Pharmacol Sci; 2011; 116(3):309-15. PubMed ID: 21691037
[TBL] [Abstract][Full Text] [Related]
2. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
[TBL] [Abstract][Full Text] [Related]
3. Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells.
Kobayashi T; Akiyama Y; Akiyama N; Katoh H; Yamamoto S; Funatsuki K; Yanagimoto T; Notoya M; Asakura K; Shinosaki T; Hanasaki K
Eur J Pharmacol; 2010 Dec; 649(1-3):23-8. PubMed ID: 20826135
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
[TBL] [Abstract][Full Text] [Related]
5. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety and tolerability of valsartan 80 mg compared to irbesartan 150 mg in hypertensive patients on long-term hemodialysis (VALID study).
Leidig M; Bambauer R; Kirchertz EJ; Szabã T; Handrock R; Leinung D; Baier M; Schmieder RE
Clin Nephrol; 2008 Jun; 69(6):425-32. PubMed ID: 18538118
[TBL] [Abstract][Full Text] [Related]
7. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
Smith DH; Dubiel R; Jones M
Am J Cardiovasc Drugs; 2005; 5(1):41-50. PubMed ID: 15631537
[TBL] [Abstract][Full Text] [Related]
8. Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension.
Taguchi I; Toyoda S; Takano K; Arikawa T; Kikuchi M; Ogawa M; Abe S; Node K; Inoue T
Hypertens Res; 2013 Jul; 36(7):608-13. PubMed ID: 23425956
[TBL] [Abstract][Full Text] [Related]
9. Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice.
Ushijima K; Takuma M; Ando H; Ishikawa-Kobayashi E; Nozawa M; Maekawa T; Shiga T; Fujimura A
Eur J Pharmacol; 2013 Jan; 698(1-3):505-10. PubMed ID: 23195328
[TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.
Derosa G; Fogari E; D'Angelo A; Cicero AF; Salvadeo SA; Ragonesi PD; Ferrari I; Gravina A; Fassi R; Fogari R
J Clin Pharm Ther; 2007 Jun; 32(3):261-8. PubMed ID: 17489878
[TBL] [Abstract][Full Text] [Related]
11. Irbesartan treatment up-regulates hepatic expression of PPARalpha and its target genes in obese Koletsky (fa(k)/fa(k)) rats: a link to amelioration of hypertriglyceridaemia.
Rong X; Li Y; Ebihara K; Zhao M; Kusakabe T; Tomita T; Murray M; Nakao K
Br J Pharmacol; 2010 Aug; 160(7):1796-807. PubMed ID: 20649581
[TBL] [Abstract][Full Text] [Related]
12. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
Bobrie G; Delonca J; Moulin C; Giacomino A; Postel-Vinay N; Asmar R;
Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL.
Coats AJ
Int J Cardiol; 2001 Jul; 79(2-3):99-102. PubMed ID: 11461726
[No Abstract] [Full Text] [Related]
14. Diverse effects of long-term treatment with imidapril and irbesartan on cell growth signal, apoptosis and collagen type I expression in the left ventricle of spontaneously hypertensive rats.
Wang JM; Wang Y; Zhu ZS; Zhang MC; Zou Y; Li JJ; Li MJ; Jiang XJ; Li XY
Life Sci; 2004 Jun; 75(4):407-20. PubMed ID: 15147828
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation.
Janke J; Schupp M; Engeli S; Gorzelniak K; Boschmann M; Sauma L; Nystrom FH; Jordan J; Luft FC; Sharma AM
J Hypertens; 2006 Sep; 24(9):1809-16. PubMed ID: 16915030
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
[TBL] [Abstract][Full Text] [Related]
17. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
[TBL] [Abstract][Full Text] [Related]
18. The antihypertensive effect of irbesartan in spontaneously hypertensive rats is associated with improvement of the leptin-adiponectin imbalance.
Weng J; Chen M; Guo R; Yang S; Liu D; Fang D
Adipocyte; 2021 Dec; 10(1):101-107. PubMed ID: 33570444
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.
Khan AH; Imig JD
Am J Hypertens; 2011 Jul; 24(7):816-21. PubMed ID: 21415842
[TBL] [Abstract][Full Text] [Related]
20. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
